TARGIMMUNE Trademark

Trademark Overview


On Monday, February 25, 2019, a trademark application was filed for TARGIMMUNE with the United States Patent and Trademark Office. The USPTO has given the TARGIMMUNE trademark a serial number of 79256339. The federal status of this trademark filing is REGISTERED as of Tuesday, March 17, 2020. This trademark is owned by TargImmune Therapeutics AG. The TARGIMMUNE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific and technological services, namely, scientific research in the field of drug development as well as research and design services relating thereto; services of industrial analyses and industrial researches in the field of drug development; providing information and data in relation to scientific and technological research and development in the field of drug development; scientific and technological services and research services, namely, drug discovery services in the field of developing immunological, pharmaceutical, immunotherapeutic and diagnostic products, in particular immunological, pharmaceutical and immunotherapeutic products, in particular for the prevention and treatment of oncological diseases; scientific and technological services and research, namely, medical research services in the field of discovery, development and formulation of medicinal products and chemical synthesis, in particular for immunological, pharmaceutical and immunotherapeutic products, in part...
targimmune

General Information


Serial Number79256339
Word MarkTARGIMMUNE
Filing DateMonday, February 25, 2019
Status700 - REGISTERED
Status DateTuesday, March 17, 2020
Registration Number6010220
Registration DateTuesday, March 17, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 31, 2019

Trademark Statements


Goods and ServicesScientific and technological services, namely, scientific research in the field of drug development as well as research and design services relating thereto; services of industrial analyses and industrial researches in the field of drug development; providing information and data in relation to scientific and technological research and development in the field of drug development; scientific and technological services and research services, namely, drug discovery services in the field of developing immunological, pharmaceutical, immunotherapeutic and diagnostic products, in particular immunological, pharmaceutical and immunotherapeutic products, in particular for the prevention and treatment of oncological diseases; scientific and technological services and research, namely, medical research services in the field of discovery, development and formulation of medicinal products and chemical synthesis, in particular for immunological, pharmaceutical and immunotherapeutic products, in particular for the prevention and treatment of oncological diseases

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 25, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTargImmune Therapeutics AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameTargImmune Therapeutics AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameTargImmune Therapeutics AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Friday, August 14, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, July 27, 2020FINAL DISPOSITION NOTICE SENT TO IB
Monday, July 27, 2020FINAL DISPOSITION PROCESSED
Wednesday, June 17, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 17, 2020REGISTERED-PRINCIPAL REGISTER
Saturday, January 4, 2020NOTIFICATION PROCESSED BY IB
Tuesday, December 31, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 31, 2019PUBLISHED FOR OPPOSITION
Wednesday, December 18, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 18, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 11, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 25, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 21, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 21, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 21, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, June 22, 2019REFUSAL PROCESSED BY IB
Monday, June 3, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, June 3, 2019REFUSAL PROCESSED BY MPU
Thursday, May 9, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, May 8, 2019NON-FINAL ACTION WRITTEN
Monday, May 6, 2019ASSIGNED TO EXAMINER
Tuesday, April 30, 2019APPLICATION FILING RECEIPT MAILED
Thursday, April 25, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, April 24, 2019LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, April 11, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB